Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus pyogenes surface antigens refer to a diverse group of cell surface-exposed proteins and carbohydrates found on the outer membrane of Streptococcus pyogenes (Group A Streptococcus, GAS), a pathogenic Gram-positive bacterium. Major types include the M protein (a major virulence determinant with over 120 known serotypes), T antigen (used in epidemiologic typing), and various other proteins such as pili, fibronectin-binding proteins, and secreted superantigens[2][3][5][6][7][1]. These antigens are central to bacterial adhesion, immune evasion, and triggering of host immune responses. They are critical targets for serological typing (e.g., Lancefield grouping), diagnostic assays, and vaccine development[1][3][4][7]. Many surface antigens are immunogenic, but some (such as M protein) exhibit molecular mimicry with host tissues, contributing to immune-mediated sequelae like rheumatic fever and glomerulonephritis[2][7]. Surface antigen profiles vary between strains and over time, making vaccine and therapeutic development challenging. Notes: - "Streptococcus pyogenes surface antigens" is not a single, canonical molecule or a classical "target" in the sense of receptors or enzymes, but a group of structurally and functionally diverse molecules.[1][2][3][7] - Individual antigens (e.g., M protein, SpeB, streptolysin O) may be separately classified and studied for drug or vaccine targeting; bulk term lumps together multiple unrelated molecules and is therefore non-specific. - These antigens are primarily relevant for vaccine development, serological diagnosis, and as virulence determinants, rather than as direct targets for classical small-molecule drugs. Key specific surface antigens and their functions: - M protein: Major determinant of immune evasion, inhibits phagocytosis, used in serotyping (emm typing), and a focal point for vaccine strategies[2][3][4][5][7]. - T antigen: Trypsin-resistant protein, used mainly for epidemiological typing, not a major vaccine target[3][6][7]. - Pili (fimbriae): Adhesins involved in tissue tropism, immune evasion, and biofilm formation[3]. - Streptolysin O and S: Hemolysins; O is immunogenic and used in serologic tests (ASO titer)[7]. - Superantigen exotoxins (SpeA, SpeC): Cause rash in scarlet fever and contribute to toxic shock[7]. - Others (fibronectin-binding proteins, capsule, etc.): Mediate adhesion and virulence; potential vaccine or diagnostic candidates[2][7][1].
Not applicable for small molecule drugs; surface antigens are targeted by antibodies or vaccine-induced immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pyogenes surface antigen.